Early Tacrolimus Dosing in Pediatric Liver Transplantation Depends on Recipient CYP3A5 and ABCB1 (or MDR1) Genotypes: Experience in Living Donor Recipients

Elens, Laure

Early Tacrolimus Dosing in Pediatric Liver Transplantation Depends on Recipient CYP3A5 and ABCB1 (or MDR1) Genotypes: Experience in Living Donor Recipients

(2013) 13th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology — Location: Salt lake city, USA (22.September.2013)

Files

No attached file found for this publication.

Details

Authors

Elens, LaureUCLouvain
Author

Affiliations

UCLouvainSSS/LDRI - Louvain Drug Research Institute

Citations

APA
Chicago
FWB

Elens, L. (2013). Early Tacrolimus Dosing in Pediatric Liver Transplantation Depends on Recipient CYP3A5 and ABCB1 (or MDR1) Genotypes: Experience in Living Donor Recipients. Therapeutic Drug Monitoring, 35(5), 709. https://hdl.handle.net/2078.5/190896 (Original work published 2013)